Dry eyes a problem with hormonal therapy

Dry eye syndrome is far more prevalent in breast cancer patients on aromatase inhibitors compared with controls, Australian researchers report.

In a study of 100 women on AI treatment, over 35% reported dry eye syndrome compared to 18% of matched controls.

Although the syndrome is generally easy to manage, only 40% of women with dry eyes sought treatment.